SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001564590-21-056383
Filing Date
2021-11-12
Accepted
2021-11-12 06:05:15
Documents
3
Group Members
BALDWIN YENCARINA CHENCARL OSCAR BROWNCHAMPIONS MANAGEMENT CO., LTD.CHE YAO CHANGCHE-YU LINCHENG-HSIEN LINCHI JEN CHENCHI PIN INVESTMENT COCHI-WEN HUNGCHIA FANG LINCHIA HUI YUCHIA HUNG LIN.CHIA-TSUNG SUCHIN-NU LINCHIN-PEN LINCHING JU OUCHING JUI LINCHUNG-

Document Format Files

Seq Description Document Type Size
1 SC 13D/A lch-sc13da.htm SC 13D/A 2965945
2 EX-99.1 lch-ex991_6.htm EX-99.1 295884
3 EX-99.2 lch-ex992_10.htm EX-99.2 30355
  Complete submission text file 0001564590-21-056383.txt   3295967
Mailing Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503
Business Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503 886 2 2655 7377
Taiwan Liposome Company, Ltd. (Subject) CIK: 0001722890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F5 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90905 | Film No.: 211398913
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2F. NO. 3 YUANQU ST., NANGANG DIST. TAIPEI F5 105
Business Address
Lin Chang-Hai (Filed by) CIK: 0001813691 (see all company filings)

Type: SC 13D/A